India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months...
On September 1, according to official sources, the Serum Institute of India (SII) and the Department of Biotechnology (DBT) will introduce India's first...
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's Covid-19 vaccine Covovax for restricted emergency use in children aged 7...
An expert panel of India's central drug authority on Friday recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7...